CD Genomics, a leading provider of comprehensive sequencing and bioinformatics services, is proud to announce its mature Human Whole Genome PacBio SMRT sequencing services. This addition to their extensive portfolio heralds a new era in genetic sequencing, offering unparalleled resolution and accuracy to researchers worldwide.

This state-of-the-art sequencing technology utilizes Single Molecule, Real-Time (SMRT) sequencing by Pacific Biosciences, renowned globally for its high-quality sequencing services. Unlike many other genome sequencing methods, SMRT sequencing can determine the entire genome – over 3 billion base pairs in humans – with robust accuracy and an impressive capacity for detecting large-scale variations.

SMRT sequencing does more than offer comprehensive genomic information; it provides a holistic view of the genome that identifies both small and large variations that could be crucial in diagnostic and therapeutic applications. This includes the ability to uncover complex genetic structures, repetitive sequences, and previously uncharted genomic regions – unexplained gaps common in other techniques.

By delivering longer read lengths, this approach allows CD Genomics' experts to obtain a complete picture of an entire DNA molecule, effectively allowing detailed detection of genomic variation, including structural variation, gene fusion, point mutation, RNA editing, and even the assessment of methylation patterns for an inclusive grasp of the biological impact of the genome.

“One of the major challenges in genomics is producing high-quality genomic data. With PacBio SMRT sequencing, we can overcome this obstacle and provide the high resolution and accuracy that the scientific community needs for numerous applications. We envision this technology paving the way for transformative research in many areas,” said the head of Research and Development at CD Genomics.

SMRT sequencing has a wide range of applications, from disease gene discovery and genome assembly to metagenomics and transcriptomics. CD Genomics’ PacBio SMRT sequencing service facilitates many research areas, such as human genetics and disease research, agrigenomics, cancer research, and microbiology, fueling advancements in understanding the genome's role in health and disease.

CD Genomics’ commitment to staying at the forefront of genomic science is highlighted by its investment in this innovative sequencing technology.

As a reputable genomic service provider with over a decade of experience in Next-Generation Sequencing (NGS), Sanger sequencing, and bioinformatics, CD Genomics continues to demonstrate its dedication to supporting researchers worldwide with access to cutting-edge genomic tools needed to drive their work forward. With their Human Whole Genome PacBio SMRT sequencing, CD Genomics is ushering in a new era of high-resolution, accurate genomic analysis.

About CD Genomics

CD Genomics stands as a premier provider of sequencing and bioinformatics services. With an unwavering dedication to quality, innovation, and customer satisfaction, CD Genomics serves researchers worldwide as they pursue groundbreaking discoveries.

Contact

Address: Shirley, NY 11967, USA

Email: contact@cd-genomics.com